Michael Cole, MD, DPhil¹, Nikhil Ranjan, PhD¹, Daniel G. Flores^1*, Molly Kuzma^1*, Alexis Reed, RN^1*, Robert A. Brodsky, MD¹ and Gloria F. Gerber, MD²

¹Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD
²Division of Hematology, Department of Medicine, Johns Hopkins Hospital, Baltimore, MD

Morag Griffin, MBChB, MRCP^1*, Richard J. Kelly, MBChB, PhD^1*, Mathilde Gavillet, MD, PhD^2*, Petra Muus, MD¹, Britta Hoechsmann, MD^3,4*, W. Jason Cummings, PhD^5*, John Efthimiou, BSc, MBBS, MD, FRCP^5*, William Pullman, BMedSc, MBBS, PhD, FRACP⁵, Hubert Schrezenmeier, MD^3,4 and Jens Panse, MD^6,7

¹Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom
²Service and Central Laboratory of Hematology, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland
³Institute of Transfusion Medicine, University of Ulm, Ulm, Germany
⁴Institute for Clinical Transfusion Medicine, German Red Cross Blood Transfusion Service and University Hospital Ulm, Ulm, Germany
⁵Omeros Corporation, Seattle, WA
⁶Universitätsklinikum RWTH, Aachen, Germany
⁷Center of Integrated Oncology (CIO), Aachen, Bonne, Cologne, Düsseldorf (ABCD), Germany

Peiyuan Dong^1,2*, Yilin Liu^3*, Zhongxing Jiang^2*, Huimin Sun^4*, Yanhong Zhao^1*, Linjie Wu^1*, Jiali Huo^1*, Jing Zhang^1*, Meili Ge^1*, Fang Dong^1*, Sha Hao^1,5* and Tao Cheng^5,6

¹State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China
²Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China, Tianjin, China
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, AL, China
⁵Tianjin Institutes of Health Science, Tianjin, China
⁶State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China

Xinyan Zhang, MS^1*, Li-Ping Guo^1*, Jin-Song Jia^1*, Ya-Zhe Wang^1*, Mi Liang^1*, Mengzhu Shen, PhD^2*, Zhenkun Wang^1*, Chen-Yuan Li^1*, Zhong-Shi Lyu, PhD^1*, Tong Xing^1*, Zhi-Wei Zhang^1*, Yuan-Yuan Zhang^1*, Xiao-Jun Huang, MD¹ and Yuan Kong, MD, PhD^1*

¹Peking University People’s Hospital, Beijing, China
²Peking University People’s Hospital, Beijing, AL, China

Arthur Sterin^1*, Cécile Renard, MD^2*, Virginie Gandemer^3*, Mony Fahd, MD MSc^4,5*, Benedicte Bruno^6*, Gaelle Stofleth^7*, Nimrod Buchbinder, MD^8*, Marie Angoso, MD^9*, Cecile Pochon^10*, Fanny Rialland Battisti, MD^11*, Marie Robin, MD^12*, Stéphanie Nguyen-Quoc, MD, PhD^13*, Jacques-Emanuel Galimard^14*, Jean-Hugues Dalle, MD, PHD¹⁵, Regis Peffault De Latour^16,17* and Flore Sicre De Fontbrune^{18,19,20,21,22,23*}

¹Department of Pediatric Hematology, Immunology and Oncology, APHM, La Timone Children Hospital, Department of Pediatric Hematology, Immunolog, Marseille, France
²Institute of Hematology and Pediatric Oncology, Lyon, France
³CHU Hopital Sud, Rennes, FRA
⁴Pediatric hematology and immunology department, Robert-Debré Hospital, GHU APHP Nord Université Paris-Cité, Paris, France
⁵Hematology and Immunology Pediatric Department, Robert-Debré Academic Hospital, GHU AP-HP Nord Université Paris Cité, Paris, France
⁶Chru Lille, Jeanne De Flandre Hématologie Pédiatrique, Lille, FRA
⁷Pôle Couple Enfants, HCE Immunohématologie et oncologie pédiatriques, grenoble, France
⁸Department of Pediatric Hematology and Oncology, Rouen University Hospital, Rouen, France
⁹CHU Bordeaux, bordeaux, France
¹⁰Department of Hematology, Centre Hospitalier Régional Universitaire (CHRU), Vandoeuvre-les-Nancy, France
¹¹Hématologie et oncologie pédiatrique, CHU Hôtel Dieu, Nantes, FRA
¹²Hopital Saint Louis, APHP, Paris, France
¹³Hematology Department, Pitié-Salpêtrière University Hospital, AP-HP, Paris, France
¹⁴EBMT Paris Study Office, Paris, FRA
¹⁵Department of Pediatric Hematology and Immunology, University Hospital Robert Debré, Assistance Publique des Hôpitaux de Paris (APHP), Paris, France
¹⁶BMT unit, Hôpital Saint-Louis,, Paris, France
¹⁷French Référence Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Paris, France
¹⁸Hematology and Transplant Unit, Saint Louis Hospital, APHP, Paris, France
¹⁹French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Saint Louis Hospital, Paris, France
²⁰Centre de Référence Aplasie Médullaire, Service d'Hématologie Greffe, Assistance Publique des Hôpitaux de Paris, Hôpital Saint-Louis, PARIS, FRA
²¹Service Hematologie Greffe, Centre de Reference des Aplasies Medullaires Acquises et Constitutionnelles, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, Paris, France
²²French National Reference Center for Aplastic Anemia, Paris, France
²³Hôpital Saint-Louis, Université Paris Cité, Paris, France

Bruno Fattizzo, MD¹, Carmelo Gurnari, MD, PhD², Sabrina Giammarco, MD, PhD^3*, Antony Ricchiuti^4*, Hussein Awada⁵, Marta Bortolotti, MD^6*, Giacinto Luca Pedone^7*, Francesco Versino, MD^8*, Dario Consonni^9*, Roochi Trikha^10*, Shreyans Gandhi, MD, MBBS, DNB, FRCPath, MPhil, MRCP^11*, Simona Sica, MD, PhD^3,12,13*, Jaroslaw Maciejewski⁵, Austin G. Kulasekararaj, MD, MBBS, FRCPath, MRCP¹⁴ and Wilma Barcellini, MD^15*

¹Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
²Cleveland Clinic Foundation, Cleveland, OH
³Dipartimento di Diagnostica per Immagini, Radioterapia Oncologica ed Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
⁴Univeristy of Milan, Milan, ITA
⁵Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁶S.C. Ematologia, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
⁷FONDAZIONE IRCCS CA' GRANDA OSPEDALE MAGGIORE POLICLINICO, MILAN, Italy
⁸University of Milan, Milano, Italy
⁹Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
¹⁰King's College Hospital NHS, London, United Kingdom
¹¹Department of Haematological Medicine, King's College Hospital NHS, London, United Kingdom
¹²UOC Ematologia e Trapianto Cellule Staminali Emopoietiche, Fondazione Policlinico Universitario A. Gemelli IRCCS Roma, Rome, Italy
¹³UNIVERSITA' CATTOLICA SACRO CUORE, ROME, ITA
¹⁴King’s College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, and King’s College London, London, United Kingdom
¹⁵Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Xijuan Lin^*, Chen Yang^*, Ziwei Liu^*, Junling Zhuang, MD, PhD, Miao Chen^* and Bing Han^*

Peking Union Medical College Hospital, Chinese Academy of Medical Science, Beijing, China

Phillip Scheinberg, MD¹, Hazza Alzahrani, MD^2*, Alejandro Contento Gonzalo^3*, Martin Höglund, MD, PhD⁴, Jin Seok Kim, MD, PhD^5*, Jens Panse, MD^6,7, Melissa J Rose, DO^8,9, Jörg Schubert, MD^10*, Yasutaka Ueda, MD, PhD¹¹, Eng Soo Yap, MBBS^12*, Muriel Buri^13*, Nicolo' Compagno, MD¹⁴, Brittany Gentile, PhD^15*, Sasha Sreckovic, MD^16* and Austin G. Kulasekararaj, MD, MBBS, FRCPath, MRCP^17,18

¹Hospital A Beneficência Portuguesa, Sao Paulo, SP, Brazil
²Department of Hematology, Stem Cell Transplantation, and Cellular Therapy, Cancer Center of Excellence, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia
³Complejo Hospitalario Central de Málaga, Málaga, Spain
⁴Department of Medical Sciences, Uppsala University, Uppsala, Sweden
⁵Yonsei University College of Medicine, Severance Hospital, Seoul, Korea, Republic of (South)
⁶Center for Integrated Oncology - Aachen Bonn Cologne Duesseldorf (CIO-ABCD), Aachen, Germany
⁷Center of Integrated Oncology (CIO), Aachen, Bonne, Cologne, Düsseldorf (ABCD), Germany
⁸Department of Pediatrics, The Ohio State University, Colombus, OH
⁹Division of Pediatric Hematology Oncology, Nationwide Children’s Hospital, Columbus, OH
¹⁰Elblandklinikum Riesa, Riesa, Germany
¹¹Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Suita, Japan
¹²Department of Laboratory Medicine, National University Hospital, Singapore, Singapore
¹³F. Hoffmann-La Roche Ltd, Basel, Switzerland
¹⁴F. Hoffmann-La Roche Ltd, Basel, Basel-Stadt, Switzerland
¹⁵Genentech, Inc., South San Francisco, CA
¹⁶Genentech, Inc, South San Francisco
¹⁷King’s College Hospital-NHS Foundation Trust, NIHR/Wellcome King’s Clinical Research Facility, and King’s College London, London, United Kingdom
¹⁸King's College London, National Institute for Health and Care Research and Wellcome King’s Research Facility, London, United Kingdom

Antonio M Risitano, MD, PhD^1,2,3, Bing Han^4*, Austin G. Kulasekararaj, MD, MBBS, FRCPath, MRCP^3,5,6,7, Yasutaka Ueda^8*, Phillip Scheinberg, MD⁹, Carlos de Castro^10*, Jaroslaw Maciejewski¹¹, Josefin Snellman^12*, Olivier Somenzi, PhD^12*, Randall Winnette^13*, Samopriyo Maitra^14*, Shujie Li^15*, Marion Dahlke, MD, MSc^12* and Regis Peffault De Latour^3,16,17*

¹AORN Moscati, Avellino, Italy
²University of Naples Federico II, Naples, Italy
³The Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation, Barcelona, Spain
⁴Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China
⁵King’s College Hospital NHS, London, United Kingdom
⁶National Institute for Health and Care Research and Wellcome King’s Research Facility, London, United Kingdom
⁷King’s College London, London, United Kingdom
⁸Osaka University Graduate School of Medicine, Suita, Japan
⁹Hospital A Beneficência Portuguesa, São Paulo, Brazil
¹⁰Duke University School of Medicine, Duke Cancer Institute, Durham, NC
¹¹Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
¹²Novartis Pharma AG, Basel, Switzerland
¹³Novartis Pharmaceutical Corporation, East Hanover, NJ
¹⁴Novartis Healthcare Private Limited, Hyderabad, India
¹⁵China Novartis Institutes for BioMedical Research Co Ltd, Shanghai, China
¹⁶French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Saint-Louis Hospital, Paris, France
¹⁷Université Paris Cité, Paris, France

Orianne Wagner-Ballon, MD, PhD¹, Jean-Philippe Vial, MD^2*, Valerie Soenen, PharmD, PhD^3*, Anna Raimbault, PharmD, PhD^4*, Camille Debord, PharmD^5*, Anne-Catherine Lhoumeau, PharmD, PhD^6*, Melanie Pannetier, PharmD^7*, Francois Vergez, DVM, Ph.D.^8*, Caroline Mayeur-Rousse, MD^9*, Marie-Christine Jacob, MD^10*, Caroline Bret, PhD, PharmD^11*, Veronique Harrivel, MD^12*, Nicolas Chapuis, PharmD, PhD^13*, Elsa Bera, MD^14*, Juliette Vo Xuan, PharmD^1*, Veronique Latger-Cannard, MD^15*, Stéphanie Mathis, PharmD^4*, Marie Loosveld, MD, PhD^16*, Gerard Socie¹⁷, Flore Sicre de Fontbrune, MD^17*, Regis Peffault de Latour, MD, PhD^17*, Ekbel Amri^18*, Yannis Bencherif^18*, Bernard Drenou, MD^19*, Agathe Debliquis, PharmD^19* and Magali Le Garff-Tavernier, PharmD, PhD^20*

¹Hematology and Immunology Department, Henri Mondor University Hospital, UPEC, IMRB, Assistance Publique Hopitaux de Paris, Créteil, France
²CHU Bordeaux, PESSAC, France
³Laboratoire d’Hématologie, CHU Lille, Lille, France
⁴Laboratory of Hematology and Flow cytometry, Saint Louis Hospital, APHP, Paris, France
⁵Nantes University Hospital, Nantes, FRA
⁶Laboratory of Hematology and Flow cytometry, Cancer Biology department, Institut Paoli-Calmettes, Marseille, France
⁷Laboratoire d’Hématologie, CHU Rennes, Rennes, France
⁸Laboratoire d'Hématologie, CHU de Toulouse - Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France
⁹Laboratory of Hematology and Flow cytometry, CHU Strasbourg, Strasbourg, France
¹⁰CHU Grenoble Alpes, La Tronche, France
¹¹CHU Montpellier, Montpellier, France
¹²Laboratory of Hematology and Flow cytometry, CHU Amiens, Amiens, France
¹³Institut Cochin, Paris, FRA
¹⁴Laboratory of Hematology and Flow cytometry, CHU Rouen, Rouen, France
¹⁵CHU Nancy, Nancy, France
¹⁶Hematology Laboratory, Marseille, FRA
¹⁷Hematology and Transplant Unit, Saint Louis Hospital, APHP, Paris, France
¹⁸Alexion Pharma France, Paris, France
¹⁹Laboratoire d’Hématologie, Groupe Hospitalier de la Région Mulhouse Sud Alsace, Mulhouse, France
²⁰Hematology Laboratory, Assistance Publique-Hôpitaux de Paris, Pitie-Salpetriere Hospital, Paris, France

W. Jason Cummings, PhD^1*, Yi Li, MS^1*, Siobhan Hayes^2*, Richard Mills^2*, Colm Farrell^2*, Morag Griffin, MBChB, MRCP^3*, J. Steve Whitaker, MD^1* and William Pullman, BMedSc, MBBS, PhD, FRACP¹

¹Omeros Corporation, Seattle, WA
²ICON Clinical Research UK Ltd, Reading, United Kingdom
³Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

Jeanette Walter, MD^1,2*, Benjamin Rolles, MD^1,2,3,4*, Yannic Schumacher^1,2*, Frauke Theis, MD^5,6*, Leo Hansmann, MD^7,8*, Markus P. Radsak, MD^9,10*, Michael Heuser, MD¹¹, Julia-Annabell Georgi, MD^12*, Jörg Chromik, MD^13*, Beatrice Drexler, MD^14*, Jörg Schubert, MD^15*, Kim Kricheldorf^1,2*, Jens Panse, MD^1,2, Thomas Stiehl^16*, Tim H. H. Brummendorf, MD^1,2, Bhavisha A. Patel, MD¹⁷, Neal S. Young, MD¹⁷, Emma M. Groarke, MD¹⁷ and Fabian Beier, MD^1,2*

¹Department of Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany
²Center for Integrated Oncology - Aachen Bonn Cologne Duesseldorf (CIO-ABCD), Aachen, Germany
³Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA
⁴Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁵Department of Internal Medicine III, Hematology, Oncology and Palliative Care, University Medical Center Rostock, Rostock, Germany
⁶University Hospital of Ulm, Ulm, Baden-Württemberg, DEU
⁷Department of Hematology, Oncology, and Tumor Immunology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
⁸Department of Internal Medicine III, Hematology and Oncology, University Hospital Regensburg, Regensburg, Germany
⁹Department of Hematology and Medical Oncology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
¹⁰DONAUISAR Klinikum, Deggendorf, Germany
¹¹Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
¹²Department of Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany
¹³Department of Medicine, Hematology/Oncology, University Hospital Frankfurt, Frankfurt, Germany
¹⁴Department of Hematology, University Hospital Basel, Basel, Switzerland
¹⁵Elblandklinikum Riesa, Riesa, Germany
¹⁶Institute for Computational Biomedicine and Disease Modeling, RWTH Aachen University, Aachen, Germany
¹⁷Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD

Tian Zhang^1*, Zixuan Liu^1*, Chunyan Liu^1*, Nan Song^1* and Rong Fu, MD^1,2,3

¹Department of Hematology, Tianjin Medical University General Hospital, Tianjin, China
²Tianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin, China
³Tianjin Institute of Hematology, Tianjin, China

Aashray Mandala, BS^1*, Carlos Bravo-Perez, MD^1,2*, Matteo D'Addona^1,3*, Zachary Brady^1*, Mark Orland, MD¹, Luca Guarnera, MD^1,4*, Kartik Lakhotiya, MS^1*, Christopher Haddad, BS^1*, Praveena Thiagarajan, MD, PhD^1*, Arooj Ahmed, MD^1*, Simona Pagliuca, MD, PhD⁵, Carmelo Gurnari, MD, PhD^4,6, Valeria Visconte, PhD⁷, Arda Durmaz, PhD^1* and Jaroslaw Maciejewski⁷

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Hematology and Medical Oncology, Hospital Universitario Morales Meseguer, University of Murcia, IMIB-Pascual Parrilla, CIBERER - Instituto de Salud Carlos III, Murcia, Spain
³Hematology and Transplant Center, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Ercolano, Italy
⁴Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
⁵Department of Hematology, Nancy University Hospital, Vandœuvre-lès-Nancy, France, France
⁶Cleveland Clinic Foundation, Cleveland, OH
⁷Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH

Hussein Awada¹, Arda Durmaz, PhD^2*, Luca Guarnera, MD^1*, Tyler Birkholz^3*, Olisaemeka Ogbue, MBBS¹, Mark Orland, MD¹, Olga Lytvynova, MD^4*, Matteo D'Addona^1*, Praveena Thiagarajan, MD, PhD^1*, Arooj Ahmed, MD^1*, Zachary Brady^1*, Carlos Bravo-Perez, MD^1*, Valeria Visconte, PhD⁵, Jaroslaw Maciejewski⁵ and Carmelo Gurnari, MD, PhD^6,7

¹Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
²Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, CLEVELAND, OH
³Department of Translational Hematology & Oncology Research, Cleveland Clinic, Cleveland, OH
⁴Department of Translational Hematology and Oncology Research, Cleveland Clinic, Cleveland
⁵Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland, OH
⁶Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy
⁷Cleveland Clinic Foundation, Cleveland, OH

Huihui Fan^1*, Wenrui Yang^1*, Xin Zhao², Li Zhang^3*, Liping Jing, MD^1* and Fengkui Zhang^4*

¹Anemia Therapeutic Center, Institute of Hematology and Blood Diseases Hospital, CAMS & PUMC, Tianjin, China
²Red Blood Cell Diseases Center & Regenerative Medicine Clinic, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
³State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences&Peking Union Medical College, Tianjin, China
⁴State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology Blood Diseases Hospital, Chinese Academy of Medical Sciences Peking Union Medical College, Tianjin, China

Regis Peffault De Latour^1,2,3*, Austin G. Kulasekararaj, MD, MBBS, FRCPath, MRCP^3,4,5,6, Phillip Scheinberg, MD⁷, Yasutaka Ueda^8*, Carlos de Castro^9*, Samopriyo Maitra^10*, Philippe Ferber^11*, Marion Dahlke, MD, MSc^11* and Antonio M Risitano, MD, PhD^3,12,13

¹French Reference Center for Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria, Saint-Louis Hospital, Paris, France
²Université Paris Cité, Paris, France
³The Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation, Barcelona, Spain
⁴National Institute for Health and Care Research and Wellcome King’s Research Facility, London, United Kingdom
⁵King's College London, London, United Kingdom
⁶King’s College Hospital NHS, London, United Kingdom
⁷Hospital A Beneficência Portuguesa, São Paulo, Brazil
⁸Osaka University Graduate School of Medicine, Suita, Japan
⁹Duke University School of Medicine, Duke Cancer Institute, Durham, NC
¹⁰Novartis Healthcare Private Limited, Hyderabad, India
¹¹Novartis Pharma AG, Basel, Switzerland
¹²AORN Moscati, Avellino, Italy
¹³University of Naples Federico II, Naples, Italy